ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 137 filers reported holding ABCELLERA BIOLOGICS INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $529,253 | -28.8% | 115,055 | 0.0% | 0.20% | -29.6% |
| Q2 2023 | $743,255 | -14.3% | 115,055 | 0.0% | 0.29% | -23.9% |
| Q1 2023 | $867,515 | -25.6% | 115,055 | 0.0% | 0.38% | -31.7% |
| Q4 2022 | $1,165,507 | -80.9% | 115,055 | -81.4% | 0.55% | -77.8% |
| Q3 2022 | $6,104,000 | -9.1% | 617,213 | -2.1% | 2.49% | -6.3% |
| Q2 2022 | $6,713,000 | +49.2% | 630,326 | +36.6% | 2.66% | +71.5% |
| Q1 2022 | $4,498,000 | -31.8% | 461,289 | 0.0% | 1.55% | -20.7% |
| Q4 2021 | $6,596,000 | -28.6% | 461,289 | 0.0% | 1.96% | -29.3% |
| Q3 2021 | $9,244,000 | – | 461,289 | – | 2.77% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $75,584,000 | 86.10% |
| Gruss & Co., LLC | 430,407 | $8,625,000 | 24.12% |
| SB Management Ltd | 9,817,190 | $196,736,000 | 20.16% |
| GUARDIAN CAPITAL ADVISORS LP | 3,836,414 | $76,767,000 | 7.97% |
| Intellectus Partners, LLC | 1,223,429 | $24,518,000 | 5.93% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $82,266,000 | 4.82% |
| ArchPoint Investors | 461,289 | $9,244,000 | 2.77% |
| Belmont Capital, LLC | 150,000 | $3,006,000 | 2.44% |
| CLOUGH CAPITAL PARTNERS L P | 971,297 | $19,465,000 | 1.18% |
| Orbimed Advisors | 4,180,768 | $83,783,000 | 0.92% |